We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.18%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$21.9B
AUM Growth
+$1.56B
Cap. Flow
+$486M
Cap. Flow %
2.22%
Top 10 Hldgs %
19.94%
Holding
3,346
New
196
Increased
1,490
Reduced
1,397
Closed
181

Sector Composition

Rank Sector Weight
1 Technology 10.43%
2 Financials 4.62%
3 Consumer Discretionary 4.22%
4 Healthcare 3.87%
5 Industrials 2.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIRY
3276
Firy Inc
FIRY
$156M
-1,127
Closed -$13K
SLDP icon
3277
Solid Power
SLDP
$543M
-10,546
Closed -$32K
SLG icon
3278
SL Green Realty
SLG
$3.98B
-8,866
Closed -$209K
SPHR icon
3279
Sphere Entertainment
SPHR
$6.26B
-5,501
Closed -$325K
SPXC icon
3280
SPX Corp
SPXC
$10.9B
-6,586
Closed -$465K
SVAL icon
3281
iShares US Small Cap Value Factor ETF
SVAL
$209M
-12,470
Closed -$332K
SXC icon
3282
SunCoke Energy
SXC
$783M
-58,285
Closed -$523K
TDF
3283
Templeton Dragon Fund
TDF
$275M
-10,407
Closed -$110K
TFII icon
3284
TFI International
TFII
$11.9B
-2,131
Closed -$254K
TILL icon
3285
Teucrium Agricultural Strategy No K-1 ETF
TILL
$33.3M
-55,975
Closed -$1.94M
TK icon
3286
Teekay
TK
$1.03B
-23,697
Closed -$146K
TNDM icon
3287
Tandem Diabetes Care
TNDM
$1.6B
-6,388
Closed -$259K
TR icon
3288
Tootsie Roll Industries
TR
$3B
-201,409
Closed -$8.28M
TRST
3289
Trustco Bank Corp NY
TRST
$970M
-8,800
Closed -$281K
UAN icon
3290
CVR Partners
UAN
$1.28B
-12,600
Closed -$1.12M
UI icon
3291
Ubiquiti
UI
$35.2B
-1,236
Closed -$336K
UP icon
3292
Wheels Up
UP
$188M
-228
Closed -$29K
UTZ icon
3293
Utz Brands
UTZ
$1.25B
-10,637
Closed -$175K
TONX
3294
TON Strategy Co
TONX
$161M
-13
Closed -$12K
VERO
3295
DELISTED
Venus Concept
VERO
-68
Closed -$2K
VIXM icon
3296
ProShares VIX Mid-Term Futures ETF
VIXM
$93.9M
-11,975
Closed -$321K
VPV icon
3297
Invesco Pennsylvania Value Municipal Income Trust
VPV
$201M
-10,085
Closed -$101K
VTGN icon
3298
VistaGen Therapeutics
VTGN
$11.7M
-852
Closed -$3K
VXX icon
3299
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$141M
-1,444
Closed -$259K
WBIY icon
3300
WBI Power Factor High Dividend ETF
WBIY
$62.6M
-28,740
Closed -$765K

Similar funds

Cambridge Investment Research Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Cambridge Investment Research Advisors held 3,346 positions worth $21.9B, up 7.6% from $20.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q2 2023 filing shows 196 new, 1,490 increased, 1,397 reduced and 181 closed positions. Its largest new stake was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $41.5M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.4% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q2 2023 buy was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M.
  • Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q2 2023, an estimated $43.6M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $41.5M.
  • Cambridge Investment Research Advisors fully exited AllianzIM U.S. Equity Buffer10 Jul ETF in Q2 2023, selling an estimated $9.73M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $21.9B portfolio in Q2 2023.
  • Cambridge Investment Research Advisors opened 196 new positions and closed 181 in Q2 2023.
  • Cambridge Investment Research Advisors's portfolio value rose 7.6% quarter-over-quarter to $21.9B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.